金吾财讯 | 强生(JNJ)绩后股价受压下行,截止发稿,跌3.68%,报142.7美元,成交额4.19亿美元
公司公布2024年第四季度业绩,营收录得225.2亿美元,按年升5.23%,预期为224.4亿美元,得益于抗癌药物的强劲销售;净利润录得34.31亿美元,按年跌15.26%,预期为47.7亿美元;每股收益为1.41美元,预期为1.79美元;经调整后每股收益为2.04美元,较上年下降近11%,但高于预期的每股2.01美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.